FMP
Monterey Bio Acquisition Corporation
MTRY
NASDAQ
Inactive Equity
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
11.14 USD
-0.03 (-0.269%)
About
ceo
Mr. Murat Omur
sector
Financial Services
industry
Shell Companies
website
https://www.montereybio.com
exchange
NASDAQ
Description
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
CIK
0001860663
ISIN
US61240F1084
CUSIP
61240F108
Address
17 State Street
Phone
917 267 0216
Country
US
Employee
N/A
IPO Date
Nov 22, 2021
Summary
CIK
0001860663
Exchange
NASDAQ
Industry
Shell Companies
Sector
Financial Services
CUSIP
61240F108
ISIN
US61240F1084
Country
US
Price
11.14
Beta
0
Volume Avg.
3.45k
Market Cap
48.3M
Shares
-
52-Week
10.21-12.0
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-85.69
P/B
-
Website
https://www.montereybio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MTRY News
It looks like there's no news available.
